دورية أكاديمية
[The treatment of nasal (nasal-type) NK-T cell lymphoma].
العنوان: | [The treatment of nasal (nasal-type) NK-T cell lymphoma]. |
---|---|
المؤلفون: | Wang C; Department of Otolaryngology, Changhai Hospital, Second Military Medical University, Shanghai 200433., Zhang S, Li Z |
المصدر: | Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology [Lin Chuang Er Bi Yan Hou Ke Za Zhi] 2003 May; Vol. 17 (5), pp. 264-5. |
نوع المنشور: | English Abstract; Journal Article |
اللغة: | Chinese |
بيانات الدورية: | Publisher: Tong ji yi ke da xue Fu shu xie he yi yuan Country of Publication: China NLM ID: 9426080 Publication Model: Print Cited Medium: Print NLM ISO Abbreviation: Lin Chuang Er Bi Yan Hou Ke Za Zhi Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: [Wuhan Shi] : Tong ji yi ke da xue Fu shu xie he yi yuan, -2006. |
مواضيع طبية MeSH: | Killer Cells, Natural*, Lymphoma, T-Cell/*therapy , Nose Neoplasms/*therapy, Adult ; Aged ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged |
مستخلص: | Objective: To discuss the treatment of nasal (nasal-type) NK-T cell lymphoma. Method: From 1993 to 2000, there were twenty one nasal (nasal-type) NK-T cell lymphoma patients treated in our department, three patients were treated with only radiotherapy, eighteen patients were treated combination radiotherapy with chemotherapy, and all patients were followed up for 1-8 years. Result: Eleven patients completely alleviated, six patients partial alleviated, four aggravated and two died. Conclusion: The prognosis of nasal (nasal-type) NK-T cell lymphoma is not satisfactory. The combination therapy for it is the optimal at present. |
تواريخ الأحداث: | Date Created: 20030815 Date Completed: 20031212 Latest Revision: 20140625 |
رمز التحديث: | 20231215 |
PMID: | 12916349 |
قاعدة البيانات: | MEDLINE |
الوصف غير متاح. |